» Authors » John T Woosley

John T Woosley

Explore the profile of John T Woosley including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 101
Citations 3045
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Ma C, Schoepfer A, Dellon E, Bredenoord A, Chehade M, Collins M, et al.
J Allergy Clin Immunol . 2021 Jul; 149(2):659-670. PMID: 34242635
Background: End points used to determine treatment efficacy in eosinophilic esophagitis (EoE) have evolved over time. With multiple novel therapies in development for EoE, harmonization of outcomes measures will facilitate...
12.
Chang N, Raja S, Betancourt R, Randall C, Keene S, Lilly A, et al.
Dig Dis Sci . 2021 Jan; 66(10):3312-3321. PMID: 33492534
Background: The relationship between histologic disease activity in eosinophilic esophagitis (EoE) and generic measures of quality of life (QoL) is unclear. Aims: To determine differences in QoL in adults with...
13.
Safroneeva E, Cotton C, Schoepfer A, Zwahlen M, Woosley J, Dellon E
Am J Gastroenterol . 2020 Oct; 115(12):2098-2102. PMID: 33009060
Introduction: We investigated whether dilation modifies the association between symptoms and esophageal eosinophilia (peak esophageal eosinophils/high-power field [eos/hpf]) in patients with eosinophilic esophagitis enrolled into a randomized trial comparing the...
14.
Cotton C, Betancourt R, Randall C, Perjar I, Bookhout C, Woosley J, et al.
Clin Gastroenterol Hepatol . 2020 Jul; 19(9):1824-1834.e2. PMID: 32634625
Background And Aims: Updated diagnostic guidelines for eosinophilic esophagitis (EoE) have eliminated the requirement for a proton pump inhibitor (PPI) trial, but there are no models to identify patients with...
15.
Dellon E, Woosley J, McGee S, Moist S, Shaheen N
Dis Esophagus . 2020 Mar; 33(6). PMID: 32193541
Inflammatory factors in eosinophilic esophagitis (EoE), including major basic protein (MBP), eotaxin-3 (EOT3) and mast cell tryptase (TRP), may predict treatment response to topical corticosteroids (tCS). We aimed to determine...
16.
Dellon E, Woosley J, Arrington A, McGee S, Covington J, Moist S, et al.
Clin Gastroenterol Hepatol . 2019 Sep; 18(7):1483-1492.e2. PMID: 31499249
Background & Aims: Eosinophilic esophagitis (EoE) is chronic and recurs if treatment is discontinued. We aimed to determine rates of recurrence, and whether initial treatment with oral viscous budesonide (OVB)...
17.
Eluri S, Perjar I, Betancourt R, Randall C, Raja S, Woosley J, et al.
Dis Esophagus . 2019 Jul; 32(9). PMID: 31329864
Non-dysphagia symptoms, such as heartburn and dyspepsia, are poorly characterized in adults with eosinophilic esophagitis (EoE). It is unclear if treatment improves these symptoms. The aim of this paper was...
18.
Dellon E, Woosley J, Arrington A, McGee S, Covington J, Moist S, et al.
Gastroenterology . 2019 Mar; 157(1):65-73.e5. PMID: 30872104
Background And Aims: Topical steroid treatments for eosinophilic esophagitis (EoE) include swallowed fluticasone from a multi-dose inhaler (MDI) or oral viscous budesonide (OVB) slurry, but the 2 have never been...
19.
Schoepfer A, Hirano I, Coslovsky M, Roumet M, Zwahlen M, Kuehni C, et al.
Clin Gastroenterol Hepatol . 2018 Nov; 17(8):1477-1488.e10. PMID: 30476587
Background & Aims: Eosinophilic esophagitis (EoE) is assessed endoscopically (endoscopic activity), based on grades of edema, rings, exudates, furrows, and strictures (EREFS). We examined variations in endoscopic assessments of severity,...
20.
Eluri S, Selitsky S, Perjar I, Hollyfield J, Betancourt R, Randall C, et al.
Clin Gastroenterol Hepatol . 2018 Sep; 17(6):1081-1088.e2. PMID: 30213583
Background & Aims: Few factors have been identified that can be used to predict response of patients with eosinophilic esophagitis (EoE) to topical steroid treatment. We aimed to determine whether...